CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
52 hedge funds and large institutions have $57.1M invested in Concert Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
48% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 21
Holders
52
Holding in Top 10
–
Calls
$164K
Puts
$81K
Top Buyers
| 1 | +$7.1M | |
| 2 | +$1.2M | |
| 3 | +$698K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$260K |
| 5 |
Morgan Stanley
New York
|
+$252K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$1.24M | |
| 3 | -$1.24M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.2M |
| 5 |
BlackRock
New York
|
-$846K |